Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam vs Dexmedetomidine vs Meperidine for Post-Spinal Shivering
NCT06627816Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nefopam in postanesthetic shivering (PAS) (3 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of Shivering at 120 minutes. Started Jan 2025; status: completed.
02
Drugs
nefopam
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT06627816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06627816.